Bausch + Lomb Corporation (BLCO)
NYSE: BLCO · Real-Time Price · USD
17.79
+0.06 (0.34%)
At close: Sep 9, 2026, 4:00 PM EDT
17.79
0.00 (0.00%)
After-hours: Sep 9, 2026, 4:41 PM EDT
Bausch + Lomb Revenue
Bausch + Lomb had revenue of $1.39B in the quarter ending June 30, 2026, with 9.08% growth. This brings the company's revenue in the last twelve months to $6.00B, up 9.28% year-over-year. In the year 2025, Bausch + Lomb had annual revenue of $5.10B with 6.47% growth.
Revenue (ttm)
$6.00B
Revenue Growth
+9.28%
P/S Ratio
1.19
Revenue / Employee
$409,538
Employees
13,000
Market Cap
6.35B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.10B | 310.00M | 6.47% |
| Dec 31, 2024 | 4.79B | 645.00M | 15.56% |
| Dec 31, 2023 | 4.15B | 378.00M | 10.03% |
| Dec 31, 2022 | 3.77B | 3.00M | 0.08% |
| Dec 31, 2021 | 3.77B | 353.00M | 10.35% |
| Dec 31, 2020 | 3.41B | -366.00M | -9.69% |
| Dec 31, 2019 | 3.78B | 113.00M | 3.08% |
| Dec 31, 2018 | 3.67B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Avantor | 6.56B |
| Align Technology | 4.14B |
| AptarGroup | 3.93B |
| MiniMed Group | 3.22B |
| Envista Holdings | 2.86B |
| Teleflex | 2.25B |
| ICU Medical | 2.16B |
| Merit Medical Systems | 1.58B |
BLCO News
- 9 hours ago - Leerink bullish on Bausch + Lomb, initiates with an Outperform - TheFly
- 11 hours ago - Bausch + Lomb initiated with an Outperform at Leerink - TheFly
- 7 days ago - Bausch + Lomb publishes new research on en Vista Aspire IOLs - TheFly
- 7 days ago - Bausch + Lomb Announces New Published Research on enVista Aspire™ Real World Experience - Business Wire
- 8 days ago - Most Women Don't Recognize Dry Eye as a Symptom of Perimenopause and Menopause, New Bausch + Lomb Survey Finds - Business Wire
- 16 days ago - Bausch + Lomb Transcript: Study result - Transcripts
- 16 days ago - Bausch + Lomb Slides: Study result - Filings
- 16 days ago - Bausch + Lomb Press release: Study result - Filings